Osteoporosis is a systemic and endocrine bone disorder distinguished by declined bone
mineral density, compromised bone strength, and destruction of trabecular structure. The …

In worldwide, osteoporosis has become one of the severe public health distress and over
200 million people get affected by tenderness and fissure during their life period. Vicenin-2 …

Osteoporosis, an age-related metabolic bone disease, is mainly caused by an imbalance
between osteoblast-mediated bone formation and osteoclast-mediated bone resorption. At …

Osteoporosis (OP) is a common chronic progressive bone disease that increases fracture
risk in postmenopausal women. Research suggests that puerarin (Pue) may be an effective …

Hyperoside, an active flavonoid glycoside isolated from many traditional Chinese medicines,
has received much attention because of its potential role in osteoporosis treatment. In the …

OBJECTIVE: To investigate whether Teriparatide (TP) contributed to the osteogenic
differentiation of human marrow mesenchymal cells (hMSCs) through the regulation of miR …

Daidzein, the most widely studied soy phytoestrogen, is not only a potential antiosteoporosis
agent owing to its possible osteogenic activity, but also shows anticancer activity. However …

Background This study aimed to explore whether S-Equol delays diabetes-induced
osteoporosis and the molecular mechanisms underlying its therapeutic effects. Materials …

Kidney Disease Improving Global Outcomes (KDIGO) 2017 Clinical Practice Guideline has
recommended treatment decisions for patients with chronic kidney disease (CKD) with …

Bone erosion is a central feature of rheumatoid arthritis (RA) that is characterized by the
infiltration of the synovial lining by osteoclasts and lymphocytes. In the present study …